Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P et al. (2026)
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease
Eur Respir J, 67 (1)
DOI 10.1183/13993003.02533-2024, PubMed 40907995

Campochiaro C, Truchetet ME, Vonk M, De Luca G, Cuomo G, Ananieva LP, Hachulla E, Smith V, Gheorghiu AM, Becvar R, Carreira P, Hunzelmann N, Furst DE, Ortiz-Santamaria V, Del Galdo F, Matucci-Cerinic M, Hoffmann-Vold AM, EUSTAR collaborators (2026)
Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR database
Arthritis Rheumatol (in press)
DOI 10.1002/art.70043, PubMed 41568546

Hoffmann-Vold AM, Antoniou K, Distler O, Crestani B (2026)
Correspondence on the 'ERS/EULAR 2025 CTD-ILD Guideline: Queries from an Indian Perspective' and on the 'ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease' by Antoniou et al.'
Ann Rheum Dis, 85 (3), e39-e41
DOI 10.1016/j.ard.2025.11.026, PubMed 41558949